cervical carcinoma
Conditions
Interventions
Cervical cancer population:Non
Sponsors
Chunlin Chen
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Diagnosis time: 2004-2016; Cervical cancer was diagnosed by cervical biopsy or after total hysterectomy. Being hospitalized for surgery or radiation treatment; Clinical medical records are complete
Exclusion criteria
Exclusion criteria: Cervical biopsy pathology consultation results of CIN and other non-cervical cancer cases; The treatment process is interrupted, such as surgery in the external hospital after receiving neoadjuvant chemotherapy. Postoperative pathological results were non-cervical malignant tumors. Concomitant with other malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Age of menarche;Reproductive status;Gestational times;Production time;Mode of production;Reproductive age;Contraceptive method;History of STD;Squamous cell carcinoma antigen;CA125;CEA;Other tumor markers;HPV;HPV type;TCT;Histologic type (biopsy);Histological grading (biopsy);Histologic type(conization);Histological grading(conization);Gross type;The maximum diameter of the tumor (first diagnosis);Tumor intermediate line (first diagnosis);Minimal diameter of tumor (first diagnosis);FIGO staging;Other diagnosis;Preoperative adjuvant therapy;Simple chemotherapy course;Synchronous radiotherapy and chemotherapy sensitization treatment;Chemotherapy alone;Sensitization chemotherapy scheme;Chemotherapy regimen;Radiotherapy scheme;Radiotherapy plan preparation;Dose of radiotherapy;The maximum diameter of the tumor (after adjuvant radiotherapy);Tumor intermediate line (after adjuvant radiotherapy);Minimal diameter of tumor (after adjuvant radiotherapy);The maximum diameter of the tumor (after the first aid);Intermediate diameter of the tumor (after the first adjuvant);Minimal diameter of tumor (after the first aid);The maximum diameter of the tumor (after second assists);Middle diameter of the tumor (after second assists);The minimum diameter of the tumor (after second assists);Preoperative adjuvant therapy time 3;The maximum diameter of the tumor (after third assists);Middle diameter of the tumor (after third assists);The minimum diameter of the tumor (after third assists);Operation date;Type of anesthesia;Operation time;Operator;Surgical approach;Type of uterus;Lymphoid type;Preoperative hemoglobin;Haemorrhage;Erythrocyte transfusion;Blood transfusion volume;Total blood transfusion;Intraoperative complications;Postoperative exhaust time;Postoperatively defecation time;The time of postoperative urethral catheterization;Discharge time of urethral catheter after operation;Postoperative residual urine;Postoperative complications;Tumor maximum diameter (Pathology);Tumor intermed | — |
Countries
China
Contacts
Public ContactChunlin Chen
Nanfang Hospital Affiliated to Southern Medical University
Outcome results
None listed